XEOMIN 100 units powder for solution for injection Malta - English - Medicines Authority

xeomin 100 units powder for solution for injection

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 100 u - muscle relaxants

XEOMIN 50 units powder for solution for injection Malta - English - Medicines Authority

xeomin 50 units powder for solution for injection

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 50 u - muscle relaxants

XEOMIN 200 units powder for solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

xeomin 200 units powder for solution for injection

merz pharmaceuticals gmbh - clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins - powder for solution for injection - 200 - other muscle relaxants, peripherally acting agents; botulinum toxin

DYSPORT clostridium botulinum type A toxin Australia - English - Department of Health (Therapeutic Goods Administration)

dysport clostridium botulinum type a toxin

ipsen pty ltd - clostridium botulinum type a toxin haemagglutinin complex, quantity: 500 u - injection, powder for - excipient ingredients: albumin; lactose monohydrate - dysport is indicated for symptomatic treatment of focal spasticity of: ? upper limbs in adults ? lower limbs in adults ? upper limbs in children aged 2 years and older ? lower limbs in children aged 2 years and older,dysport is indicated in adults for the treatment of: ? spasmodic torticollis ? blepharospasm ? hemifacial spasm ? moderate to severe glabellar lines and / or lateral canthal lines (crow?s feet)

BOTOX botulinum toxin, type A purified neurotoxin complex 100U injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

botox botulinum toxin, type a purified neurotoxin complex 100u injection vial

abbvie pty ltd - botulinim toxin type a, quantity: 100 u - injection, powder for - excipient ingredients: albumin; sodium chloride - botox (botulinum toxin type a) purified neurotoxin complex is indicated for the following therapeutic indications: treatment of overactive bladder with symptoms of urinary incontinence, urgency, and frequency, in adult patients who have an inadequate response to or are intolerant of an anticholinergic medication. treatment of urinary incontinence due to neurogenic detrusor overactivity resulting from a defined neurological illness (such as spinal cord injury or multiple sclerosis) and not controlled adequately by anticholinergic agents. prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). treatment of strabismus in children and adults.treatment of blepharospasm associated with dystonia, including benign blepharospasm and viith nerve disorders (specifically hemifacial spasm) in patients twelve years and older. treatment of cervical dystonia (spasmodic torticollis). treatment of focal spasticity of the upper and lower limbs, including dynamic equinus foot deformity, due to juvenile cerebral palsy in patients two years and older. treatment of severe primary hyperhidrosis of the axillae. treatment of focal spasticity in adults. treatment of spasmodic dysphonia. botox (botulinum toxin type a) purified neurotoxin complex is indicated for the following cosmetic indications: temporary improvement in the appearance of upper facial rhytides (glabellar lines, crow's feet and forehead lines) in adults.

Cisatracurium-AFT New Zealand - English - Medsafe (Medicines Safety Authority)

cisatracurium-aft

aft pharmaceuticals ltd - cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v - solution for injection - 2 mg/ml - active: cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium-AFT New Zealand - English - Medsafe (Medicines Safety Authority)

cisatracurium-aft

aft pharmaceuticals ltd - cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v - solution for injection - 5 mg/ml - active: cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Dysport New Zealand - English - Medsafe (Medicines Safety Authority)

dysport

pharmacy retailing (nz) ltd t/a healthcare logistics - clostridium botulinum type a toxin haemagglutinin complex 300 u - powder for injection - 300 u - active: clostridium botulinum type a toxin haemagglutinin complex 300 u excipient: albumin lactose monohydrate - dysport is also indicated for the symptomatic treatment of axillary hyperhidrosis (excessive sweating)

Xeomin New Zealand - English - Medsafe (Medicines Safety Authority)

xeomin

pharmacy retailing (nz) ltd t/a healthcare logistics - botulinum toxin type a 100 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a - powder for injection - 100 units - active: botulinum toxin type a 100 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a excipient: albumin sucrose - xeomin is indicated in adults for the treatment of: · cervical dystonia · blepharospasm · spasticity of the upper limb · upper facial lines -glabellar frown lines -lateral periorbital lines (crow's feet) - horizontal forehead lines

Xeomin New Zealand - English - Medsafe (Medicines Safety Authority)

xeomin

pharmacy retailing (nz) ltd t/a healthcare logistics - botulinum toxin type a 50 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a - powder for injection - 50 units - active: botulinum toxin type a 50 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a excipient: albumin sucrose - xeomin is indicated in adults for the treatment of: · cervical dystonia · blepharospasm · spasticity of the upper limb · upper facial lines -glabellar frown lines -lateral periorbital lines (crow's feet) - horizontal forehead lines